NEWS AND PRESS RELEASES

Aker ASA and Aker Capital AS (jointly “Aker”) announces that its subsidiary Aker BioMarine AS ("Aker BioMarine" or the “Company”), has engaged Arctic Securities AS, DNB Markets, a part of DNB Bank ASA, and Skandinaviska Enskilda Banken AB (publ.) (Oslo branch), (the “Joint Bookrunners”), to assist the Company in a contemplated private placement (the “Private Placement”) of new shares in the Company followed by a listing of its shares on Merkur Market (the “Listing”). The Company further intends to proceed with a listing on the Oslo Stock Exchange (“OSE”) within Q1 2021. Aker BioMarine is a marine ingredients company which has over recent years invested significantly in additional capacity and building a fully integrated value chain, which now positions the Company for strong further growth.

Shrimp farmers seek growth and feed efficiency for their crops, but this can be challenging when water salinity concentration in commercial ponds is high. In a new study, now published in the Journal of Applied Aquaculture, scientists from Instituto de Ciências do Mar (Labomar), Brazil and Aker BioMarine evaluate whether high salinity conditions can be offset with the dietary supplementation of astaxanthin krill oil and soybean oil.

Do you want to showcase your skills and gain insight into Aker companies for the opportunity to become a summer intern in 2018? 

Aker BioMarine and Neptune announce closing of $US34 million transaction to accelerate business and industry development.

We have been awarded the prize as Norway’s most innovative company by Innovasjonsmagasinet.

Aker BioMarine generated revenues of USD 117 million, equivalent to 11 percent growth compared to 2015.

Join us for a special anniversary celebration at Vitafoods 2017!

 U.S. lawsuit against Olympic Holding, Rimfrost, Emerald Fisheries and their partners Avoca and Bioriginal discontinued.

Aker BioMarine discusses SDGs at Sustainable Brands Copenhagen.

Learn more about the newly launched Omega-3 Index Project at Engredea/Natural Products Expo West

Aker BioMarine has commissioned a new environmentally-friendly krill harvesting vessel for NOK 1 billion. The vessel will be constructed in Norway by VARD.

Luhua Biomarine and its U.S. distributor Infiniti Nutraceuticals agree to withdraw Luhua’s krill oil products from the U.S. market.

Quick and easy Omega-3 Test offers an early warning for heightened risk of heart disease.

Historic progress in the conservation of the Antarctic and Southern Ocean at this year’s CCAMLR meeting.

Aker BioMarine is excited to introduce Superba Boost, a new krill oil concentrate that is commercially available for the US market.

The two parties recognize the patents’ strength and ending all litigation.

A research study with Infantry Officers will test the effects of krill oil concentrate on resiliency and performance.

For the second year in a row, Aker BioMarine is the only reduction fishery reported in “very good condition”.

We will exhibit at SuperZoo 2016 in Las Vegas, USA.

Innovation and commitment to sustainability are driving forces behind the company’s success and market growth.

We will exhibit at Interzoo 2016 in Nuremberg, Germany.

Our first krill oil concentrate product features higher phospholipid content and omega-3s and qualifies for 4 EU-authorized health claims.

We will host a product launch event and participate in several speaking opportunities.

Solid 20% year-on-year volume growth in Qrill™ Aqua, our krill meal used in feeds for shrimp, marine fish and salmonids.

Aker BioMarine has hired two new employees at its company headquarters in Norway.

Unveiling of Flexitech™ at the Natural Products Expo West-Engredea show in Anaheim, CA.

Visit us to learn more about the latest news.

Superba Krill oil receives product approval from Food Safety Standards Authorities of India (FSSAI).

 We have formally entered a comment period for the renewal of our Marine Stewardship Council (MSC) certification.